Hugo Tanno

1.5k total citations
47 papers, 995 citations indexed

About

Hugo Tanno is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Hugo Tanno has authored 47 papers receiving a total of 995 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hepatology, 27 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in Hugo Tanno's work include Hepatitis C virus research (19 papers), Liver Disease Diagnosis and Treatment (18 papers) and Hepatitis B Virus Studies (16 papers). Hugo Tanno is often cited by papers focused on Hepatitis C virus research (19 papers), Liver Disease Diagnosis and Treatment (18 papers) and Hepatitis B Virus Studies (16 papers). Hugo Tanno collaborates with scholars based in Argentina, United States and Italy. Hugo Tanno's co-authors include Oscar Fay, Julio Vorobioff, Eduardo Picabea, R Villavicencio, Isabelle Morel, Emanuel Lerner, R. J. Groszmann, Fernando Bessone, Jorge Findor and Hugo Fainboim and has published in prestigious journals such as The Lancet, Annals of Internal Medicine and Gastroenterology.

In The Last Decade

Hugo Tanno

46 papers receiving 946 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hugo Tanno Argentina 15 814 745 246 104 87 47 995
Mirta Ciocca Argentina 15 883 1.1× 723 1.0× 303 1.2× 188 1.8× 157 1.8× 57 1.1k
Alexandra E. Read United States 12 618 0.8× 565 0.8× 309 1.3× 70 0.7× 32 0.4× 13 857
H Schwacha Germany 12 268 0.3× 324 0.4× 304 1.2× 63 0.6× 22 0.3× 24 689
Binnur Pınarbaşı Türkiye 16 243 0.3× 263 0.4× 144 0.6× 64 0.6× 39 0.4× 47 550
Juan Antonio Casellas Spain 15 397 0.5× 425 0.6× 495 2.0× 84 0.8× 8 0.1× 42 1.1k
B. Berris Canada 15 334 0.4× 423 0.6× 34 0.1× 60 0.6× 37 0.4× 42 598
Anna Boroń‐Kaczmarska Poland 14 466 0.6× 490 0.7× 76 0.3× 160 1.5× 15 0.2× 64 751
Marie Chevallier France 14 337 0.4× 348 0.5× 84 0.3× 26 0.3× 16 0.2× 54 746
Magali Bouvier‐Alias France 21 1.3k 1.6× 1.2k 1.7× 36 0.1× 364 3.5× 100 1.1× 49 1.6k
C. Fernández‐Gutiérrez Spain 13 208 0.3× 262 0.4× 80 0.3× 98 0.9× 20 0.2× 33 510

Countries citing papers authored by Hugo Tanno

Since Specialization
Citations

This map shows the geographic impact of Hugo Tanno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugo Tanno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugo Tanno more than expected).

Fields of papers citing papers by Hugo Tanno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hugo Tanno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugo Tanno. The network helps show where Hugo Tanno may publish in the future.

Co-authorship network of co-authors of Hugo Tanno

This figure shows the co-authorship network connecting the top 25 collaborators of Hugo Tanno. A scholar is included among the top collaborators of Hugo Tanno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugo Tanno. Hugo Tanno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bessone, Fernando, Antonella Ferrari, Nelia Hernández, et al.. (2022). Nitrofurantoin-induced liver injury: long-term follow-up in two prospective DILI registries. Archives of Toxicology. 97(2). 593–602. 17 indexed citations
2.
Acosta, Julián, et al.. (2021). Zoonotic transmission of hepatitis E virus in a pig farmer from Argentina: A case report. Zoonoses and Public Health. 69(3). 235–241. 4 indexed citations
3.
Bruno, Savino, John M. Vierling, Rafael Esteban, et al.. (2012). Efficacy and safety of boceprevir plus peginterferon–ribavirin in patients with HCV G1 infection and advanced fibrosis/cirrhosis. Journal of Hepatology. 58(3). 479–487. 40 indexed citations
5.
Moreno‐Navarrete, José María, et al.. (2011). HLA-DRB1 as a risk or resistance factor in Autoimmune Hepatitis. 30(4). 115–118. 2 indexed citations
6.
Paladino, Natalia, Ana Claudia Flores, Hugo Fainboim, et al.. (2009). The most severe forms of type I autoimmune hepatitis are associated with genetically determined levels of TGF-β1. Clinical Immunology. 134(3). 305–312. 26 indexed citations
7.
Villanova, Gabriela Vanina, Daniela Gardiol, Virginia Reggiardo, et al.. (2007). Strategic Approach To Produce Low-Cost, Efficient, and Stable Competitive Internal Controls for Detection of RNA Viruses by Use of Reverse Transcription-PCR. Journal of Clinical Microbiology. 45(11). 3555–3563. 10 indexed citations
8.
Queiroz, Dulciene Maria Magalhães, et al.. (2006). Association Between Helicobacter pylori Infection and Cirrhosis in Patients with Chronic Hepatitis C Virus. Digestive Diseases and Sciences. 51(2). 370–373. 39 indexed citations
9.
Vorobioff, Julio, David Kravetz, Eduardo Picabea, et al.. (2002). Effects of long-term propranolol and octreotide on postprandial hemodynamics in cirrhosis: A randomized, controlled trial. Gastroenterology. 122(4). 916–922. 27 indexed citations
10.
Fernández, José Luís, et al.. (2002). Use of a mathematical model to estimate the time of response to the treatment of chronic hepatitis C. Journal of Hepatology. 36. 234–234. 1 indexed citations
11.
Pando, Marcelo J., J. Larriba, Gabriela Fernández, et al.. (1999). Pediatric and adult forms of type I autoimmune hepatitis in argentina: Evidence for differential genetic predisposition. Hepatology. 30(6). 1374–1380. 153 indexed citations
12.
Vorobioff, Julio, R. J. Groszmann, Eduardo Picabea, et al.. (1996). Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: A 10-year prospective study. Gastroenterology. 111(3). 701–709. 224 indexed citations
13.
Tanno, Hugo, et al.. (1995). Hepatitis C virus RNA and long‐term response to recombinant interferon‐α2b in patients with chronic hepatitis C. Journal of Viral Hepatitis. 2(2). 97–102. 15 indexed citations
14.
Таnака, К., Y. Yamanoi, H. Noumi, et al.. (1994). Development of radiation-resistant magnet coils for high-intensity beam lines. IEEE Transactions on Magnetics. 30(4). 2511–2514. 9 indexed citations
15.
Thomas, H. C., Anna S. Lok, V. Carreño, et al.. (1994). Comparative study of three doses of interferon‐α2a in chronic active hepatitis B. Journal of Viral Hepatitis. 1(2). 139–148. 28 indexed citations
16.
Tanno, Hugo, et al.. (1990). Recombinant interferon alfa-2b following prednisone withdrawal in the treatment of chronic type B hepatitis. Journal of Hepatology. 11. S113–S117. 30 indexed citations
17.
Tanno, Hugo, et al.. (1988). Biphasic form of hepatitis A virus infection: a frequent variant in Argentina. Liver International. 8(1). 53–57. 14 indexed citations
18.
Tanno, Hugo, et al.. (1988). HBeAg/Anti‐HBe seroconversion during and after protracted immunosuppressive treatment in type B chronic hepatitis. Journal of Medical Virology. 25(1). 45–51. 5 indexed citations
19.
Feinman, S.V., B. Berris, Oscar Fay, et al.. (1988). Serum HBV-DNA (hepatitis B virus DNA) in acute and chronic hepatitis B infection.. PubMed. 11(4). 286–91. 2 indexed citations
20.
Tanno, Hugo, et al.. (1975). LP-X in cholestasis.. PubMed. 22(5). 289–91. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026